An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Drug Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a flourishing market exists on Telegram, where communities with numerous of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users administering products of unknown origin.
Some experts stated the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Platform Response and Material Elimination
Based on the social media company, the service has removed problematic material and prohibited related keywords and search suggestions. The company said it was committed to maintaining the service safe and investing in enhancing enforcement strategies.
Digital Trading Operations
Research also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of users, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.
Within minutes of entering one community, a seller shared WhatsApp details, where most transactions take place. The seller provided an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Product Information and Pricing
Within these communities, posts show dark colored parcels with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram said it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has already seen patients injured by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental product not yet authorized … may expose users to potentially serious medical dangers”.
